… tested the role of adjuvant chemotherapy or chemoradiation in pancreatic cancer, and the
… For this review, the evidence for adjuvant therapy in pancreatic cancer was examined, and …

… of pancreatic cancer, adjuvant chemotherapy with a modified FOLFIRINOX regimen led to
significantly longer disease-free survival and overall survival than adjuvant chemotherapy with …

… Pancreatic cancer remains one of the leading causes of cancer related death worldwide
with an … Adjuvant chemotherapy has been shown to improve 5-year survival to 20%-25% but …

… largest trial in pancreatic cancer. The results demonstrated that the current best adjuvant
treatment is … radiotherapy, adjuvant chemoradiotherapy and neo-adjuvant therapies. The use of …

… adjuvant therapy of pancreatic cancer have been based. 10 They also form the basis for the
National Comprehensive Cancer Network Pancreatic … adjuvant therapy of pancreatic cancer …

… Pancreatic cancer is a major cause of cancer death; and despite advances in the standards
… with advanced pancreatic cancer has indicated a role for adjuvant therapy for patients with …

… Pancreatic cancer is a challenging malignancy to treat, as less than one-fifth of diagnosed
… It is one of the leading causes of cancer-related mortality. Adjuvant therapy has been …

… The RTOG (Radiation Therapy Oncology Group)-9704 trial … Austria that compared adjuvant
gemcitabine with observation … randomised clinical trials of adjuvant therapy suggest that (i) …

… demonstrated the feasibility of undertaking trials in pancreatic cancer. This has resulted in
a … resectable pancreatic cancer. The role of adjuvant therapy in resected pancreatic cancer …

… Survival for patients with pancreas cancer is correlated to stage. … Current accepted standard
of care is adjuvant gemcitabine … trials evaluating adjuvant therapy in pancreatic cancer are …